Name
#152 Barriers in COVID-19 Oral Antivirals (OAVs) in Long Term Care Facilities: A Clinical Perspective
Speakers
Content Presented on Behalf of
USPHS/USSG
Session Type
Posters
Room#/Location
Prince Georges Exhibit Hall A/B
Focus Areas/Topics
Clinical Care
Learning Outcomes
1. Identify barriers to access for LTC facilities.
2. Identify barriers to clinical practice in LTC facilities.
3. Identify ways to advocate for access in vulnerable populations.
2. Identify barriers to clinical practice in LTC facilities.
3. Identify ways to advocate for access in vulnerable populations.
Session Currently Live
Description
An article published in JAMA in August 2023, highlighted a list of 15,438 nursing homes analyzed by the Center for Medicare and Medicaid Services (CMS). Of that total list, 5,705 were “never used facilities.” The article referred to data from 31 May 2021 through 25 December 2022 (McGarry, Gandhi & Barnett, 2023). "Never Used Facilities refers to nursing homes identified in a recent JAMA Network Research Letter* as not having oral antiviral (OAV) or monoclonal antibody use. To connect with "never used facilities" to identify barriers in regard to access, administration, ordering hesitancy, of OAVs to their residents.